- Book
- March 2019
- 282 Pages
- Book
- December 2018
- 245 Pages
- Book
- September 2018
- 237 Pages
From €114EUR$129USD£100GBP
- Book
- July 2018
- 257 Pages
- Book
- February 2018
- 128 Pages
From €114EUR$129USD£100GBP
- Report
- December 2025
- 119 Pages
United States
From €2199EUR$2,495USD£1,931GBP
- Report
- December 2025
- 123 Pages
United States
From €2199EUR$2,495USD£1,931GBP
- Newsletter
- December 2025
- 4 Pages
Global
From €176EUR$200USD£155GBP
-
Journal - December 2025
- 60 Pages
Global
From €375EUR$425USD£329GBP
-
Journal - December 2025
- 46 Pages
Global
From €375EUR$425USD£329GBP
-
Journal - December 2025
- 64 Pages
Global
From €375EUR$425USD£329GBP
-
Journal - December 2025
- 46 Pages
Global
From €375EUR$425USD£329GBP
-
Journal - December 2025
- 58 Pages
Global
From €375EUR$425USD£329GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more